The iFuse Implant System is a minimally invasive surgical system made up of titanium implants covered in a porous plasma spray that works as an interference surface fit to help decrease implant motion, according to the release.
SI-BONE received FDA clearance for the iFuse system in Nov. 2008 and anticipates CE Mark certification in Europe. US surgeons are preparing to present initial clinical data at spine meetings this fall, according to the release.
Read the news release on SI-BONE iFuse implant system.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
